Search research articles
Contact Us
Filters
Showing results (31-40 of 46) with videos related to
Page
of 5
Sort By:
Journal of Molecular Biology
|
September 20, 2005
The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy
Nathan T Wright, Kristen M Varney, Karen C Ellis, et al.
Protein Science : a Publication of the Protein Society
|
January 23, 2019
Obscurin is a semi-flexible molecule in solution
Jacob A Whitley, Aidan M Ex-Willey, Daniel R Marzolf, et al.
Journal of Molecular Biology
|
May 20, 2009
Solution structure of S100A1 bound to the CapZ peptide (TRTK12)
Nathan T Wright, Brian R Cannon, Paul T Wilder, et al.
Circulation. Genomic and Precision Medicine
|
July 1, 2020
<i>SOS1</i> Gain-of-Function Variants in Dilated Cardiomyopathy
Jason R Cowan, Lorien Salyer, Nathan T Wright, et al.
Neuromuscular Disorders : NMD
|
May 26, 2020
Collagen VI-related limb-girdle syndrome caused by frequent mutation in COL6A3 gene with conflicting reports of pathogenicity
Janis Stavusis, Ieva Micule, Nathan T Wright, et al.
Journal of Molecular and Cellular Cardiology
|
August 23, 2017
Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway
Maegen A Ackermann, Brendan King, Nicole A P Lieberman, et al.
The Journal of Biological Chemistry
|
December 20, 2007
S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling
Benjamin L Prosser, Nathan T Wright, Erick O Hernãndez-Ochoa, et al.
The Journal of Biological Chemistry
|
March 19, 2026
Obscurin A localizes near the cell membrane to modulate stress fiber dynamics and cell migration
Kamrin D Shultz, Stephanie N Ouderkirk, Yasmin F Al Anbari, et al.
Annals of Neurology
|
April 27, 2019
Novel mutations in MYBPC1 are associated with myogenic tremor and mild myopathy
Janis Stavusis, Baiba Lace, Jochen Schäfer, et al.
Science Advances
|
June 21, 2017
Deregulated Ca<sup>2+</sup> cycling underlies the development of arrhythmia and heart disease due to mutant obscurin
Li-Yen R Hu, Maegen A Ackermann, Peter A Hecker, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 46) with videos related to
Sort By:
Page
of 5
Journal of Molecular Biology
|
September 20, 2005
The three-dimensional solution structure of Ca(2+)-bound S100A1 as determined by NMR spectroscopy
Nathan T Wright, Kristen M Varney, Karen C Ellis, et al.
Protein Science : a Publication of the Protein Society
|
January 23, 2019
Obscurin is a semi-flexible molecule in solution
Jacob A Whitley, Aidan M Ex-Willey, Daniel R Marzolf, et al.
Journal of Molecular Biology
|
May 20, 2009
Solution structure of S100A1 bound to the CapZ peptide (TRTK12)
Nathan T Wright, Brian R Cannon, Paul T Wilder, et al.
Circulation. Genomic and Precision Medicine
|
July 1, 2020
<i>SOS1</i> Gain-of-Function Variants in Dilated Cardiomyopathy
Jason R Cowan, Lorien Salyer, Nathan T Wright, et al.
Neuromuscular Disorders : NMD
|
May 26, 2020
Collagen VI-related limb-girdle syndrome caused by frequent mutation in COL6A3 gene with conflicting reports of pathogenicity
Janis Stavusis, Ieva Micule, Nathan T Wright, et al.
Journal of Molecular and Cellular Cardiology
|
August 23, 2017
Novel obscurins mediate cardiomyocyte adhesion and size via the PI3K/AKT/mTOR signaling pathway
Maegen A Ackermann, Brendan King, Nicole A P Lieberman, et al.
The Journal of Biological Chemistry
|
December 20, 2007
S100A1 binds to the calmodulin-binding site of ryanodine receptor and modulates skeletal muscle excitation-contraction coupling
Benjamin L Prosser, Nathan T Wright, Erick O Hernãndez-Ochoa, et al.
The Journal of Biological Chemistry
|
March 19, 2026
Obscurin A localizes near the cell membrane to modulate stress fiber dynamics and cell migration
Kamrin D Shultz, Stephanie N Ouderkirk, Yasmin F Al Anbari, et al.
Annals of Neurology
|
April 27, 2019
Novel mutations in MYBPC1 are associated with myogenic tremor and mild myopathy
Janis Stavusis, Baiba Lace, Jochen Schäfer, et al.
Science Advances
|
June 21, 2017
Deregulated Ca<sup>2+</sup> cycling underlies the development of arrhythmia and heart disease due to mutant obscurin
Li-Yen R Hu, Maegen A Ackermann, Peter A Hecker, et al.
Page
of 5